Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vascular smooth muscle cell contractile machinery is the integrated network of proteins and signaling pathways in VSMCs that mediates vascular tone by regulating contraction and relaxation of blood vessels[1][2][3][5][6]. Central components include actin and myosin filaments for cross-bridge cycling, myosin light chain kinase (MLCK), myosin light chain phosphatase (MLCP), the contractile cytoskeleton (notably α-smooth muscle actin), and a variety of ion channels (particularly L-type calcium channels). Contraction is primarily initiated by increased intracellular calcium, which triggers calmodulin-mediated activation of MLCK, resulting in phosphorylation of myosin light chains and thus actin-myosin interaction. In addition, G protein–coupled receptors (for agents such as angiotensin II, endothelin-1, and norepinephrine) activate phospholipase C signaling, leading to both calcium mobilization and protein kinase C activation, further modulating contraction and vascular tone[2][3][5]. This machinery is essential for blood pressure regulation, but dysregulation is implicated in hypertension, atherosclerosis, and related vascular diseases[1][5][6]. Key point: "Vascular smooth muscle cell contraction machinery" is a physiological/molecular process, not a discrete protein, receptor, or canonical drug target. As such, it is considered not a "target" in the strict drug discovery sense, and so "is_incorrect" is marked true. Targeting this machinery pharmacologically involves modulating its components (e.g., ion channels, kinases, GPCRs), many of which are themselves validated therapeutic targets[1][2][3].
Inhibition of calcium influx; Blockade of G protein–coupled receptor (GPCR)–mediated signaling; Inhibition of actin-myosin interaction; Modulation of myosin light chain phosphorylation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular smooth muscle cell contractile apparatus (VSMC contractile apparatus (not standard; usually not abbreviated in this context)).